IDXX Idexx Laboratories Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: IDXX

Price (delayed)

$556.93

Market cap

$43.88B

P/E Ratio

38.86

Dividend/share

N/A

EPS

$14.33

Enterprise value

$44.75B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 94

IDEXX Laboratories, Inc., is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We ...

Highlights
IDXX's price to earnings (P/E) is 23% lower than its 5-year quarterly average of 50.2 and 13% lower than its last 4 quarters average of 44.8
The company's EPS rose by 18% YoY and by 4.6% QoQ
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.idexx.com
Peers: NEOG WOOF HSIC ABT

Key stats

What are the main financial stats of IDXX

IDXX stock price

How has the Idexx Laboratories stock price performed over time
Intraday
2.03%
1 week
1.08%
1 month
0.81%
1 year
-12.02%
YTD
-17.68%
QTD
5.79%

Financial performance

How have Idexx Laboratories's revenue and profit performed over time
Revenue
$4.55B
Gross profit
$2.84B
Operating income
$1.46B
Net income
$1.14B
Gross margin
62.4%
Net margin
25%
The company's net income rose by 16% YoY and by 4.1% QoQ
IDXX's operating income is up by 16% YoY and by 3.7% from the previous quarter
The gross profit has increased by 14% YoY and by 3.1% QoQ
IDXX's revenue is up by 13% year-on-year and by 2.4% since the previous quarter

Price vs fundamentals

How does IDXX's price correlate with its fundamentals

Growth

What is Idexx Laboratories's growth rate over time

Valuation

What is Idexx Laboratories stock price valuation
IDXX P/E details
P/E
38.86
P/B
27.24
P/S
9.66
EV/EBIT
30.6
EV/EBITDA
27.69
EV/Sales
9.83
IDXX's price to earnings (P/E) is 23% lower than its 5-year quarterly average of 50.2 and 13% lower than its last 4 quarters average of 44.8
The company's EPS rose by 18% YoY and by 4.6% QoQ
The price to book (P/B) is 34% less than the 5-year quarterly average of 41.1 and 10% less than the last 4 quarters average of 30.2
The company's equity rose by 11% YoY and by 3.6% QoQ
The P/S is 15% below the 5-year quarterly average of 11.4 and 12% below the last 4 quarters average of 11.0
IDXX's revenue is up by 13% year-on-year and by 2.4% since the previous quarter

Efficiency

How efficient is Idexx Laboratories business performance
Idexx Laboratories's return on invested capital has increased by 17% YoY and by 5% QoQ
Idexx Laboratories's return on equity has increased by 12% YoY
The return on assets rose by 12% year-on-year and by 3.1% since the previous quarter
The company's return on sales rose by 2.6% YoY

Dividends

What is IDXX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IDXX.

Financial health

How did Idexx Laboratories financials performed over time
The company's total assets is 88% higher than its total liabilities
The quick ratio has increased by 8% YoY and by 3.2% QoQ
IDXX's current ratio is up by 5% year-on-year and by 4.5% since the previous quarter
The debt is 34% less than the equity
IDXX's debt to equity is down by 20% YoY and by 4.3% QoQ
The debt has contracted by 12% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.